MariMed Inc. (OTCMKTS:MRMD – Get Free Report) saw a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 18,486 shares, a growth of 1,748.6% from the October 15th total of 1,000 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 761,607 shares, the short-interest ratio is currently 0.0 days.
MariMed Price Performance
MRMD stock traded down $0.00 during trading on Tuesday, hitting $0.07. The stock had a trading volume of 1,568,230 shares, compared to its average volume of 869,401. The company has a current ratio of 0.92, a quick ratio of 0.34 and a debt-to-equity ratio of 1.78. The company’s 50-day moving average price is $0.07 and its two-hundred day moving average price is $0.07. MariMed has a twelve month low of $0.04 and a twelve month high of $0.16.
MariMed (OTCMKTS:MRMD – Get Free Report) last issued its quarterly earnings results on Wednesday, August 12th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). MariMed had a negative return on equity of 10.71% and a negative net margin of 9.13%. The firm had revenue of $41.92 million during the quarter, compared to analysts’ expectations of $39.80 million.
About MariMed
MariMed, Inc. is a U.S.-based cannabis company that develops, operates and manages licensed cannabis cultivation, processing and dispensary facilities. The company serves both medical and adult-use markets, where permitted by state law, and focuses on producing and distributing cannabis flower, concentrates, edibles, tinctures and other cannabis-infused products. MariMed markets products under brands that have included Betty’s Eddies, Nature’s Heritage, InHouse and Kalm Fusion. Its products are sold through the company’s retail operations and third-party dispensaries in its operating markets.
Featured Articles
- Five stocks we like better than MariMed
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
